VR Logo

Neuland Laboratories Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

38 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1984

Chairman: Davuluri Rama Mohan Rao

Managing Director: Davuluri Rama Mohan Rao

Group: --

Listing: NSE: NEULANDLAB, BSE: 524558

Headquarters: Hyderabad, Telangana

Website: www.neulandlabs.com

Key Facts

Market cap: R 565.61 Cr

Revenue (TTM): R 743.73 Cr

Earnings (TTM): R 32.14 Cr

Cash: R 45.34 Cr

Total Debt: R 231.46 Cr

Promoters' ownership: 35.86%

Liquidity: High

52 Week range: R 380.25 - 827.30

Face value: R10.00

Shares outstanding: 1,28,29,889

Stock Performance

Time Period Neuland Laboratories S&P BSE Healthcare S&P BSE Small Cap
YTD5.335.785.94
1 month-5.550.69-2.24
3 months-5.056.018.68
1 Year-31.364.547.32
3 Years-21.23-2.532.22
5 Years6.43-1.985.13
10 Years18.4611.386.14
As on 24-Feb-2020
Year Neuland Laboratories S&P BSE Small Cap S&P BSE Healthcare
2019-12.17-6.85-3.55
2018-48.48-23.41-5.89
2017-13.5159.640.49
201629.881.77-12.88
201559.176.7615.06
201461.6869.2447.43
2013172.29-11.2322.55

Review & Analysis